These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15080998)

  • 1. Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease.
    Nizi E; Koch U; Ontoria JM; Marchetti A; Narjes F; Malancona S; Matassa VG; Gardelli C
    Bioorg Med Chem Lett; 2004 May; 14(9):2151-4. PubMed ID: 15080998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P4 cap modified tetrapeptidyl alpha-ketoamides as potent HCV NS3 protease inhibitors.
    Sun DX; Liu L; Heinz B; Kolykhalov A; Lamar J; Johnson RB; Wang QM; Yip Y; Chen SH
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4333-8. PubMed ID: 15261297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenethyl amides as novel noncovalent inhibitors of hepatitis C virus NS3/4A protease: discovery, initial SAR, and molecular modeling.
    Colarusso S; Koch U; Gerlach B; Steinkühler C; De Francesco R; Altamura S; Matassa VG; Narjes F
    J Med Chem; 2003 Jan; 46(3):345-8. PubMed ID: 12540231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease.
    Venkatraman S; Velazquez F; Wu W; Blackman M; Chen KX; Bogen S; Nair L; Tong X; Chase R; Hart A; Agrawal S; Pichardo J; Prongay A; Cheng KC; Girijavallabhan V; Piwinski J; Shih NY; Njoroge FG
    J Med Chem; 2009 Jan; 52(2):336-46. PubMed ID: 19102654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease.
    Chen KX; Njoroge FG; Prongay A; Pichardo J; Madison V; Girijavallabhan V
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4475-8. PubMed ID: 16112859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 protease.
    Chen KX; Njoroge FG; Pichardo J; Prongay A; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2006 Jan; 49(2):567-74. PubMed ID: 16420042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of glycine alpha-ketoamide HCV NS3 protease inhibitors: effect of carboxylic acid isosteres.
    Han W; Jiang X; Hu Z; Wasserman ZR; Decicco CP
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3487-90. PubMed ID: 15982872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
    Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
    Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent ketoamide inhibitors of HCV NS3 protease derived from quaternized P1 groups.
    Venkatraman S; Velazquez F; Wu W; Blackman M; Madison V; Njoroge FG
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2151-5. PubMed ID: 20226659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile.
    Arasappan A; Padilla AI; Jao E; Bennett F; Bogen SL; Chen KX; Pike RE; Sannigrahi M; Soares J; Venkatraman S; Vibulbhan B; Saksena AK; Girijavallabhan V; Tong X; Cheng KC; Njoroge FG
    J Med Chem; 2009 May; 52(9):2806-17. PubMed ID: 19371095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibitors of HCV-NS3 protease derived from boronic acids.
    Venkatraman S; Wu W; Prongay A; Girijavallabhan V; George Njoroge F
    Bioorg Med Chem Lett; 2009 Jan; 19(1):180-3. PubMed ID: 19022670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors.
    Ortqvist P; Peterson SD; Kerblom E; Gossas T; Sabnis YA; Fransson R; Lindeberg G; Helena Danielson U; Karlén A; Sandström A
    Bioorg Med Chem; 2007 Feb; 15(3):1448-74. PubMed ID: 17113777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
    Njoroge FG; Chen KX; Shih NY; Piwinski JJ
    Acc Chem Res; 2008 Jan; 41(1):50-9. PubMed ID: 18193821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profiles.
    Bogen SL; Pan W; Ruan S; Nair LG; Arasappan A; Bennett F; Chen KX; Jao E; Venkatraman S; Vibulbhan B; Liu R; Cheng KC; Guo Z; Tong X; Saksena AK; Girijavallabhan V; Njoroge FG
    J Med Chem; 2009 Jun; 52(12):3679-88. PubMed ID: 19456105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease.
    Duan D; Li Z; Luo H; Zhang W; Chen L; Xu X
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6041-4. PubMed ID: 15546725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
    Dahl G; Sandström A; Akerblom E; Danielson UH
    Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease.
    Ontoria JM; Di Marco S; Conte I; Di Francesco ME; Gardelli C; Koch U; Matassa VG; Poma M; Steinkühler C; Volpari C; Harper S
    J Med Chem; 2004 Dec; 47(26):6443-6. PubMed ID: 15588076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibitors of the hepatitis C virus NS3 protease: design and synthesis of macrocyclic substrate-based beta-strand mimics.
    Goudreau N; Brochu C; Cameron DR; Duceppe JS; Faucher AM; Ferland JM; Grand-Maître C; Poirier M; Simoneau B; Tsantrizos YS
    J Org Chem; 2004 Sep; 69(19):6185-201. PubMed ID: 15357576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capped dipeptide alpha-ketoacid inhibitors of the HCV NS3 protease.
    Nizi E; Koch U; Ponzi S; Matassa VG; Gardelli C
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3325-8. PubMed ID: 12392743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent triazolyl-proline-based inhibitors of HCV NS3 protease.
    Naud J; Lemke C; Goudreau N; Beaulieu E; White PD; Llinàs-Brunet M; Forgione P
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3400-4. PubMed ID: 18448339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.